0001214659-25-004920.txt : 20250327 0001214659-25-004920.hdr.sgml : 20250327 20250327204051 ACCESSION NUMBER: 0001214659-25-004920 CONFORMED SUBMISSION TYPE: SCHEDULE 13D/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20250327 DATE AS OF CHANGE: 20250327 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: 23andMe Holding Co. CENTRAL INDEX KEY: 0001804591 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 871240344 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SCHEDULE 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-91734 FILM NUMBER: 25781150 BUSINESS ADDRESS: STREET 1: 870 MARKET STREET STREET 2: ROOM 415 CITY: SAN FRANCISCO STATE: CA ZIP: 94102 BUSINESS PHONE: (650) 938-6300 MAIL ADDRESS: STREET 1: 870 MARKET STREET STREET 2: ROOM 415 CITY: SAN FRANCISCO STATE: CA ZIP: 94102 FORMER COMPANY: FORMER CONFORMED NAME: VG Acquisition Corp. DATE OF NAME CHANGE: 20200915 FORMER COMPANY: FORMER CONFORMED NAME: Virgin Group Acquisition Corp. DATE OF NAME CHANGE: 20200909 FORMER COMPANY: FORMER CONFORMED NAME: Bleecker Street Acquisition Corp. DATE OF NAME CHANGE: 20200225 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Zentree Investments Ltd CENTRAL INDEX KEY: 0001946012 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SCHEDULE 13D/A BUSINESS ADDRESS: STREET 1: 65 CHULIA STREET STREET 2: #45-04 OCBC CENTRE CITY: SINGAPORE STATE: U0 ZIP: 049513 BUSINESS PHONE: 6566351950 MAIL ADDRESS: STREET 1: 65 CHULIA STREET STREET 2: #45-04 OCBC CENTRE CITY: SINGAPORE STATE: U0 ZIP: 049513 SCHEDULE 13D/A 1 primary_doc.xml SCHEDULE 13D/A 0001214659-25-004427 0001946012 XXXXXXXX LIVE 1 Class A Common Stock, par value $0.0001 per share 03/25/2025 false 0001804591 90138Q306 23andMe Holding Co.
870 MARKET STREET ROOM 415 SAN FRANCISCO CA 94102
Richard Magides 65 69557665 c/o Zentree Investment Mgmt Pte Ltd 18 Robinson Road Level 15-01 Singapore U0 048547 0001946012 N Zentree Investments Limited WC N E9 0.00 3249236.00 0.00 3249236.00 3249236.00 N 16.0 OO Y Richard Magides PF N X0 0.00 3249236.00 0.00 3249236.00 3249236.00 N 16.0 IN Class A Common Stock, par value $0.0001 per share 23andMe Holding Co. 870 MARKET STREET ROOM 415 SAN FRANCISCO CA 94102 Zentree Investments Limited Richard Magides Zentree Investments Limited c/o Zentree Investment Management Pte Ltd 18 Robinson Road Level 15-01 Singapore 048547 Richard Magides c/o Zentree Investment Management Pte Ltd 18 Robinson Road Level 15-01 Singapore 048547 Zentree Investments Limited: An exempt company incorporated in the Cayman Islands Richard Magides: Director Neither of the Reporting Persons has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). Neither of the Reporting Persons has, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws; Zentree Investments Limited: Citizenship The Cayman Islands Richard Magides: Citizenship British Zentree Investments Limited: Available net assets were used to purchase the shares of Class A Common Stock referred to in this Schedule 13D. Richard Magides: Personal funds were used to purchase the shares of Class A Common Stock referred to in this Schedule 13D. We want to ensure that minority investors are afforded a voice, thereby ensuring fair treatment. We seek to prevent the sale of the company at an unreasonable price and advocate for more prudent management of the company's costs. Additionally, we appeal that Class A and Class B shares be granted equal rights. We urge the management to act in the best interests of all shareholders and to address any conflicts of interest between management and investors. Percentage of class: 16.0% As of the close of business on March 25, 2025, Zentree Investments Limited and Mr. Magides may be deemed to have beneficially owned 3,249,236 Class A Common Stock of the Issuer outstanding (see Item 5(b) below). This percentage was calculated based on 20,340,344 shares of Class A Common Stock, outstanding as of March 6, 2025, as provided by the Issuer. As of the close of business on March 25, 2025, Zentree Investments Limited and Richard Magides beneficially owned a total of 3,249,236 Class A Common Stock of the Issuer, representing 3,249,236 Class A Common Stock nominal value $0.0001 per share. Of this amount Zentree Investments Limited owns 416,643 shares and Mr. Magides owns 2,832,593 shares. Richard Magides is the director of Zentree Investments Limited and may be deemed to have shared voting control and investment discretion over securities owned by Zentree Investments Limited. Richard Magides Zentree Investments Limited Not applicable Not applicable We have no contracts, arrangements, understandings or relationships with respect to securities of the issuer. We only have limited contact with the investor relations representative. Exhibit 99.1 - Transaction Description Zentree Investments Limited /s/ Richard Magides Director 03/26/2025 Richard Magides /s/ Richard Magides Director 03/26/2025 EX-99.1 2 ex99_1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

Richard Magides

 

Date   Action   Price   Shares   Broker   Trade amt
21/3/2025   Bought   1.75   7,000   UBS CH   12,250
21/3/2025   Bought   1.71   1,403   UBS CH   2,399
24/3/2025   Bought   0.9   10,000   UBS CH   9,000
24/3/2025   Bought   0.89   25,000   UBS CH   22,250
24/3/2025   Bought   0.9   20,000   UBS CH   18,000
24/3/2025   Bought   0.86   25,000   UBS CH   21,500
24/3/2025   Bought   0.8   10,000   UBS CH   8,000
24/3/2025   Bought   0.774981   100,000   UBS CH   77,498
24/3/2025   Bought   0.795895   50,000   UBS CH   39,795
25/3/2025   Bought   0.64694   100,000   UBS CH   64,694
25/3/2025   Bought   0.65   10,000   UBS CH    6,500
25/3/2025   Bought   0.65   10,000   UBS CH    6,500
25/3/2025   Bought   0.7   10,000   UBS CH    7,000

 

Zentree Investments Limited

 

Date   Action   Price   Shares   Broker   Trade amt
25/3/2025   Bought   0.642053   100,000   UBS SG    64,205
25/3/2025   Bought   0.639523   100,000   UBS SG    63,952
25/3/2025   Bought   0.625616   31,643   UBS SG   19,796